-
Kitsap Respiratory Illness Report: Week 12 (3/16/2025-3/22/2025)
In week ending March 22, local indicators for influenza continued to decrease but remained high, while local indicators for RSV remained elevated, and indicators for COVID-19 remained low. Other Puget Sound counties observed similar trends. Regional laboratory surveillance most frequently detected influenza A and rhinovirus among clinical respiratory specimens. 1.3% of emergency department (ED) visits were attributable to influenza, and…
-
Health Advisory: COVID-19 Updates for Providers
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Emerging Diseases and Conditions, Health Alert, Immunization, Immunizations, News and Alerts, News and Update, Notifiable Conditions, Novel Coronavirus, Provider Resources, VaccineActions Requested Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: People who are moderately or severely immunocompromised should: Complete their primary series of 2 mRNA (Pfizer-BioNTech or Moderna) doses, a third dose at least 28 days after the initial two-dose series and an mRNA…
-
Kitsap Respiratory Illness Report January 30 – February 5, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 1.30.22 – 2.5.22.
-
02/14/22 Health Advisory: CDC Updated Covid-19 Vaccination Guidelines; FDA Postponed its pediatric Covid-19 Vaccination Review
COVID-19 Updates for Providers Requested actions Be aware, on February 11, the Centers for Disease Control and Prevention updated their guidance for COVID-19 vaccination to include: For people who are moderately or severely immunocompromised: People who have completed a primary series of an mRNA vaccine (Pfizer-BioNTech or Moderna) are recommended to receive an mRNA booster…
-
Health Advisory: COVID-19 Updates
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, Immunizations, News and Alerts, Notifiable Conditions, Novel Coronavirus, Provider Resources, VaccineActions Requested Discuss a fourth dose of COVID-19 vaccine with immunocompromised patients. The Centers for Disease Control and Prevention (CDC) recommends people ages 5 and older who are moderately or severely immunocompromised should get an additional primary shot (third dose) of an mRNA vaccine 28 days after receiving their second dose. An additional primary shot…
-
Kitsap Respiratory Illness Report January 23 – January 29, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 1.23.22 – 1.29.22.
-
02/01/22 Health Advisory: FDA Provides Full Approval For Spikevax
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Notifiable Conditions, Provider Resources, UncategorizedCOVID-19 Updates for Providers Requested actions Be aware, U.S. Food and Drug Administration (FDA) granted full authorization to Moderna COVID-19 vaccine for people 18 years or older. Evidence shows the vaccine is safe and effective and manufactured with high quality. The vaccine will now be called Spikevax but has the same formulation as emergency use…
-
Health Advisory: COVID-19 Updates to Transferring Residents Between Long-Term Care and other Healthcare Settings
Advisory or Update, COVID-19, Emerging Diseases and Conditions, Health Advisory, Health Alert, News and Alerts, News and Update, Novel CoronavirusActions Requested Be aware, Washington Department of Health updated the Interim Guidance for Transferring Residents between Long-Term Care and other Healthcare Settings to address health care system capacity shortages. The interim guidance, effective January 21, 2022 until February 18, 2022, waives guidance asking facilities to pause admissions with identified healthcare personnel or facility acquired COVID-19…
-
Kitsap Respiratory Illness Report January 9 – January 15, 2022
Click here to access the latest Kitsap Respiratory Illness Report: 1.9.22 – 1.15.22.
-
Kitsap Respiratory Illness Report January 2 – January 8, 2022
Click here to access latest Kitsap Respiratory Illness Report: 1.2.22 – 1.8.22.
-
Health Advisory: CDC updated antiviral guidance
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Health Alert, Immunization, News and Alerts, News and Update, Notifiable Conditions, Novel Coronavirus, Provider Resources, SchoolsActions Requested Be aware, Centers for Disease Control and Prevention (CDC) updated its COVID-19 monoclonal antibody treatment recommendations. Sotrovimab monoclonal antibody formulation retains significant efficacy against Omicron, the dominant circulating variant. Other monoclonal antibody formulations under emergency use authorization (EUA)—bamlanivimab and etesevimab and casirivimab and imdevimab—lack clinical benefit against Omicron and should not be used…
-
01/06/22 Health Advisory: Booster Eligibility Expanded
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesCOVID-19 Updates for Providers Requested actions Be aware, Centers for Disease Control and Prevention (CDC) endorsed Advisory Committee on Immunization Practices’ (ACIP’s) decision to strongly recommend a single Pfizer COVID-19 vaccine booster dose for people 12–17 years old at least 5 months after their primary series. This expands the age of booster access and strengthens…
